Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3107941 | Clinical Queries: Nephrology | 2014 | 6 Pages |
Abstract
Antiphospholipid antibody syndrome (APS) is characterized by recurrent pregnancy losses and/or thrombotic events (both arterial and venous) with persistently positive lupus anticoagulant or antiphospholipid antibodies. Activation of complements, platelets and endothelial cells by the anticardiolipin-β2GP-1 complex plays a major role in pathogenesis of thrombosis. Treatment is with anticoagulation (warfarin/heparin), with steroids needed in the presence of catastrophic APS or cytopenias. Upto a third of patients may have significant long term morbidity.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Jyoti R. Parida, Durga Prasanna Misra, Anupam Wakhlu, Vikas Agarwal,